World Vaccine Congress Asia brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D
 

World Vaccine Congress Asia 2012
(全球疫苗学会:亚洲、2012年)
2012年6月11-14日 | 新加坡

是能与业界领导人交换意见的宝贵机会

World Vaccine Congress Asia中,在疫苗研究开发领域领导全球的大人物齐聚一堂,针对研究领域和事业领域新的重要课题展开热烈的讨论,并寻求解决方法。

能聆听相关各公司主管们的意见,与在此业界负起重要作用者商谈或深入交往的此学会,是为对全球疫苗团体有很大影响力、负起将来发展的领导者举行的会议。

  • 在2天的学会和1日的研究会中,有100人以上的演讲者登场
  • 预定有90场以上的会议,连续40小时进行充实的讨论
  • 预定进行20小时以上为了建构人际关系的活动

Sponsors

Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions LLC at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012

 
 

在World Vaccine Congress Asia 2012中

  • 能学习进入新市场的方法
  • 能学习强化制造能力的方法
  • 能学习与在亚洲各国展开事业的临床试验外包机关建构策略性合作关系的方法
  • 能学习与以各种水平开发疫苗的亚洲生物技术企业建构合作关系的方法
  • 能学习以因应热带病和亚洲地区地方病的疫苗共同开发作为目的,使合作成功的方法

能获得有助于扩大事业的优异构思。

World Vaccine Congress Asia 2012的主要主题
 

  • 公共医疗制度的改革、法规整备、预防接种
  • 设定国家级疫苗计划的优先顺序
  • 因应全球新市场的需求
  • 进入全球规模市场的策略
  • 亚洲流行性感冒疫苗事业的发展
  • 研究开发、合作、投资
  • 亚洲地区防止全国大流行和感染性疾病的策略

是不容错过能获知该领域技术创新最新动向的学会。
 

全球最高层疫苗解决方案提供商参加此学会的理由

  • 为了向来自亚洲各国各公司高阶主管宣传自家公司的品牌
  • 为了提高是业界销售龙头的知名度
  • 为了获得锁定的顾客等与参加费用有相乘效果的好处
  • 为了进入亚洲有前景的疫苗市场
  • 为了与在亚洲地区展开事业的企业高阶主管建构人际关系

是今年举行的活动中,为促进行销和事业开发最重要的学会。
 

推荐参加的5个理由

  • 集合在疫苗业界的关联企业和团体等总括产品部门和事业部门的500人以上高阶主管
  • 策略、研究开发、临床、制造、细胞培养等超过专业的100人最高负责人级与副社长级进行演讲
  • 举行为了研究发表的专门论坛,由40人以上的研究人员进行海报会议
  • 网罗全部疫苗价值链的4个学会在一样的会场举行
World Vaccines Congress is al meeting of vaccine buyers and sellers, NGOs, health authorities, regulators, vaccine  and other stakeholders in Asia!
 

World Vaccine Congress Asia的主要特徵

  • 能聆听听业界有关人员说明实际体验的信息: 行政机关、制药公司、生物技术关系的演讲者占全部的85%,能期待有个充实的议论
  • 质和量都充实的学会: 是由重点演讲、个案研究、专题讨论会、各种部会等100场以上的会议构成的综合性计画,能因应事业面的各种需求
  • 能遇到企业和团体的上级负责主管: 制造商、品牌、事业部门、管道等的负责人将大量参加
  • 是全球规模的学会: 预定有来自30个以上国家的参加者,网罗全部主要的地区和大陆
  • 是超过20小时的社交活动:与在业界内担任指导作用者建构人际关系
 

 Limited speaking opportunities available for leading solutin providers

World Vaccine Trials Congress Asia 2012 is about Advancing vaccine clinical development in Asia for pharmas, biotechs and partners

World Vaccine Trials Congress Asia 2012

Advancing vaccine clinical development in Asia for pharmas, biotechs and partners

Advance your clinical trials effectively and efficiently and overcome the biggest hurdle to placing your vaccine candidate on the market.

Learn how to:

  • Leverage on Asia’s clinical research capabilities to reduce R&D cost for vaccines
  • Access a wider patient pool in Asia for trials for both adult and pediatric vaccines
  • Navigate around regulatory complexities in conducting vaccine clinical trials in Asia
  • Develop successful strategies in conducting vaccine clinical trial that are cost effectively and efficiently in Asia
  • Identify and meet suitable CROs and other partners that have specialty in handling vaccines
  • Identify the most suitable site locations to conduct vaccine trials in Asia

You’ll come away with great new ideas to do better business.
 

World Vaccine Manufacturing Congress Asia 2012 is about Manufacturing innovation for Pharma, Biotechs and Partners 

World Vaccine Manufacturing Congress Asia 2012

Adopt production capabilities and establish robust and efficient manufacturing processes for vaccine development and manufacturing advances.

Learn how to:

  • Reduce Drug manufacturing cost for vaccines
  • Outsource vaccine manufacturing but maintaining quality
  • Find the right partners either globally or in Asia that meets their needs and standards
  • Ensure intellectual property protection while outsourcing to third parties
  • Ensure regulatory compliance for Asia markets and to address the global concerns on quality, reliability and authenticity
  • Ensure manufacturing plants receive Asian regulatory  approval for exports
  • Integrate the latest and advanced technological solutions
  • Increase competitive edge against competition
  • Expand their business internationally to cover the international market
  • Increase customer base
  • Meet potential partners

You’ll come away with great new ideas to do better business.

World Vaccine Partnering Congress Asia 2012 is about Innovation, licensing, and partnership opportunities for pharmas, biotechs, and partners 

World Vaccine Partnering Congress Asia 2012

Advance vaccine development effectively with innovation, partnering and discovery opportunities.

Learn how to:

  • Scout for potential biotechs or pharmas to acquire or collaborate with
  • Establish industry leadership and strengthen branding in the region
  • Educate and attract the industry on how you could possibly work with them through collaboration, licensing or M&A
  • Source for funding from pharmas and investors
  • Develop a successful strategy for pipelines from R&D to commercialization
  • Find partners to accelerate commercialization
  • Find biotechs or pharmas with highest ROIs
  • Manage risks in investing in start-ups to mid size companies

Come away with new ideas and new strategies to do better business.
 

  
Choose your language
Japanese
Korean
English

产业会议汇总历
Sponsors
Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions LLC at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012